🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 714.40 +0.4% NASDAQ 100: 663.25 +0.3% Dow Jones: 494.48 +1.2%

Peapod Lane Capital - Q1 2026 13F Filings

PE

Peapod Lane Capital LLC

CIK: 0002050979
Address: New York Bedford Hills 2 Depot Plz
$121.9 M
Portfolio Value
62
Assets Held
Reporting Period: Q1 2026
Filing Status:
Active
Last Updated: 05/02/2026

Portfolio Summary (Q1 2026)

View Full Portfolio Analysis

Top Buys

Q1 2026
1. SEG Seaport Entertainment Group
+$1.97 M
2. LAB Standard Biotools
+$1.86 M
3. INGN Inogen
+$1.59 M
4. TUSK Mammoth Energy Services
+$1.51 M
5. KELYA Kelly Services
+$1.51 M

Top Sells

Q1 2026
1. IWM Ishares Russell 2000 Etf
−$4.86 M
2. ANRO Alto Neuroscience
−$4.52 M
3. BH Biglari Holdings
−$4.12 M
4. ALTO Alto Ingredients
−$3.75 M
5. CLYM Climb Bio
−$3.11 M

Asset Allocation

Stocks/ETFs
+3.71%
$121.9 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Peapod Lane Capital Q1 2026 Filing Summary

Peapod Lane Capital LLC filed its 13F report for Q1 2026 on May 02, 2026. The portfolio totaled 121.9 M reflecting a +3.71% change from the prior quarter, spanning 62 assets. The top 10 holdings comprised 30.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 9 new positions and 6 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Peapod Lane Capital’s Q1 2026 Filing

Peapod Lane Capital submitted their Form 13F-HR for the Q1 2026 period on 05/02/2026. This was the only submission for the quarter.

In the Q1 2026 filing, Peapod Lane Capital reported a managed portfolio value of 121.9 M, consisting of 62 individual positions.

This page displays the raw filing documents. To see which stocks Peapod Lane Capital bought or sold during Q1 2026, please visit Peapod Lane Capital's Portfolio Analysis page.